
UroMems reports positive outcomes in first-ever female-only study of smart implant for incontinence
UroMems announced that the entire treatment cohort in the first-of-its-kind study in female patients successfully reached its primary endpoints.

UroMems announced that the entire treatment cohort in the first-of-its-kind study in female patients successfully reached its primary endpoints.

When even the most highly trained surgeons perform procedures on the retina—one of the smallest, most delicate parts of the human body—the stakes are high. Surgeons must account for patients’ breathing, snoring, and eye movements, along with their own involuntary hand tremors, while they work on a layer of cells less than a millimeter thick.

Endomyocardial biopsy (EMB) is a valuable method for diagnosing a range of cardiac conditions, but there is a risk of complications due to its invasive nature. Researchers have now found a way to combine right ventricular (RV) septal EMB, exploiting the benefit of 3D curved conduction system pacing (CSP) sheaths, with subsequent cardiac implantable electronic device (CIED, devices like pacemakers or defibrillators to regulate heart rhythm) implantation, using the same sheath.

DUBLIN, Ohio, Feb. 20, 2025 /PRNewswire/ — Atreon Orthopedics, LLC, a Columbus based innovator in tissue healing and regenerative technologies, announces the 510(k) clearance from the Food and Drug Administration (FDA) and the full market launch of BioCharge® Autobiologic Matrix, a bioresorbable synthetic implant designed to address biological failure modes in rotator cuff repair while improving repair integrity and long-term patient outcomes.

ANN ARBOR, Mich., Feb. 20, 2025 /PRNewswire/ — Lynx Dx, a leader in innovative diagnostic solutions, today announced the commercial launch of MyProstateScore 2.0 (MPS2) for at-home collection by patients. The test kit, ordered by a physician, is now available to patients and is eligible for Medicare reimbursement.

FragFold, developed by MIT Biology researchers, is a computational method with potential for impact on biological research and therapeutic applications.

Melbourne-based scientists have, for the first time, discovered how to “switch off” a molecule which is one of the top culprits behind prostate cancer, and is also linked to lung and kidney cancers.

A research team from Sinai Health and the University of Toronto has identified a way to determine which mothers are more likely to deliver a baby preterm, raising the possibility of developing a universal screening strategy.

In parts of the world where traveling to a clinic for routine blood tests is a financial and logistical challenge, HIV patients increasingly have the option to collect and ship a drop of their blood in paper-based devices that absorb the sample and store it for analysis in far-away labs.

Zwitterions sound like a distant cousin of Twitter (X), but in fact they are a common macromolecule found in human cells. Scientists at the University of Sydney are also now using Zwitterions to create materials that could stop blood clots from forming in medical devices and implants.